Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of May 21, 2026, DARE trades at $2.34 with a market cap of $31.61M and a P/E ratio of -2.46. DARE moved +5.11% today. Year to date, DARE is +17.09%; over the trailing twelve months it is -19.38%. Its 52-week range spans $1.27 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DARE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DARE recently traded at $2.34. Market cap is $31.61M. P/E ratio is -2.46. Revenue is $1.16M.
| Metric | Value |
|---|---|
| Price | $2.34 |
| Market Cap | $31.61M |
| P/E Ratio | -2.46 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.19 |
| 52-Week Low | $1.27 |
| Volume | 540 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.16M |
| Net Income | $-12.02M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.03M | $-13.40M | $-1.20 |
| 2024 | $9.78K | $-4.05M | $-0.48 |
| 2023 | $2.81M | $-30.16M | $-0.35 |
| 2022 | $10.00M | $-30.95M | $-0.37 |
2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.